Skip to main content
. 2017 Aug 17;12(8):e0183306. doi: 10.1371/journal.pone.0183306

Table 6. Costs and quality of life detriments associated with rotavirus vaccination at a coverage of 94.7% during 2015–2019 and without vaccination.

Cost category Mean (0.20; 0.80) cost without vaccination
(€ 1000)
Mean (0.20; 0.80) cost with vaccination
(€ 1000)
Avoided
Mean (%)
(€ 1000)
Healthcare costs GP consultations 822 (456;1 091) 256 (142; 340) 566 (69%)
EOC consultations 508 (250; 685) 158 (67; 236) 350 (69%)
Inpatient visits 16 288 (13 171; 18 967) 4 538 (3 645; 5 302) 11 750 (72%)
Outpatient visits 673 (621; 719) 187 (171; 202) 486 (72%)
Productivity losses Home care 47 805 (34 683; 57 205) 19 696 (14 256; 23 597) 28 109 (59%)
Primary care 16 793 (14 614; 18 704) 6 091 (5 275; 6 798) 10 702 (64%)
Hospital care 4 868 (3 348; 5 920) 1 577 (1 078; 1 924) 3 291 (68%)
QALY detriments Morbidity 212 (182; 243) 50 (32; 69) 137 (65%)
Mortality 57 (0; 116) 15 (0; 22) 43 (75%)
Vaccination costs Rotarix® 0 (0; 0) 21 640 (20 996; 22 200) NA
RotaTeq® 0 (0; 0) 22 580 (21 802; 23 248) NA